These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 7369735)
21. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model]. Berezina TA; Uteshev BS Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420 [TBL] [Abstract][Full Text] [Related]
22. [Antitumor activity of doxorubicin in respect to solid tumors in mice]. Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE Antibiot Med Biotekhnol; 1986 Nov; 31(11):866-70. PubMed ID: 3813509 [TBL] [Abstract][Full Text] [Related]
23. [Repair of DNA damage caused by the antineoplastic antibiotic carminomycin]. Trenin AS Vestn Akad Med Nauk SSSR; 1981; (5):71-5. PubMed ID: 7281960 [No Abstract] [Full Text] [Related]
24. Cell surface effects of adriamycin and carminomycin immobilized on cross-linked polyvinyl alcohol. Wingard LB; Tritton TR; Egler KA Cancer Res; 1985 Aug; 45(8):3529-36. PubMed ID: 4016734 [TBL] [Abstract][Full Text] [Related]
25. Comparative toxicity of carminomycin, rubomycin and adriamycin in mice and experience with carminomycin in spontaneous tumors of dogs. Syrkin AB; Kiselev AV Oncology; 1980; 37 Suppl 1():67-70. PubMed ID: 6935578 [TBL] [Abstract][Full Text] [Related]
26. [The effectivity of carminomycin in combination with dibromodulcitol on human tumor cells in vitro (author's transl)]. Projan A; Nissen E; Tanneberger S Arch Geschwulstforsch; 1981; 51(6):497-502. PubMed ID: 7332443 [TBL] [Abstract][Full Text] [Related]
28. [Formation of free radicals during interaction of adriamycin and carminomycin with xanthine oxidase]. Ledenev AN; Peskin AV; Konstantinov AA; Ruuge EK Biofizika; 1986; 31(3):519-21. PubMed ID: 3013324 [TBL] [Abstract][Full Text] [Related]
29. [Action of carminomycin on the structural integrity, primary damage susceptibility and postradiation regeneration of the DNA from Erhlich's ascitic carcinoma]. Paranosenkova VI; Saenko AS Antibiotiki; 1980 Apr; 25(4):289-94. PubMed ID: 7369734 [TBL] [Abstract][Full Text] [Related]
30. [Synthesis and antitumor action of 14-N-substituted derivatives of rubomycin and karminomycin]. Olsuf'eva EN; Povarov LS; Salimova EI; Volkolupova OP; Makukho LV Antibiot Med Biotekhnol; 1987 Apr; 32(4):254-9. PubMed ID: 3631931 [TBL] [Abstract][Full Text] [Related]
31. [Cross resistance in tumor cells and staphylococci with respect to anthracycline-group antineoplastic antibiotics]. Shorin VA; Averbukh LA Antibiotiki; 1976 Oct; 21(10):914-9. PubMed ID: 999240 [TBL] [Abstract][Full Text] [Related]
32. [Carminomycin in combination with some cytostatics. 1. Efficacy in leukemia L1210]. Nowak C; Arnold W; Henneberger G; Tanneberger S Arch Geschwulstforsch; 1983; 53(1):45-52. PubMed ID: 6860085 [TBL] [Abstract][Full Text] [Related]
33. [Antitumor activity of carminomycin antibiotic used orally]. Shorin VA; Bazhanov VS; Averbukh LA Antibiotiki; 1976 Nov; 21(11):1005-7. PubMed ID: 1037187 [TBL] [Abstract][Full Text] [Related]
34. [Effect of carminomycin on the structural integrity, primary susceptibility to radiation damage and the postradiation repair of the cellular DNA-membrane complex in Ehrlich's ascitic carcinoma]. Paranosenkova VI; Saenko AS Antibiotiki; 1981 Apr; 26(4):306-10. PubMed ID: 7235672 [TBL] [Abstract][Full Text] [Related]
35. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)]. Nowak C; Arnold W; Henneberger G; Tanneberger S Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818 [TBL] [Abstract][Full Text] [Related]
36. [Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice]. Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE Antibiotiki; 1984 Nov; 29(11):861-6. PubMed ID: 6524889 [TBL] [Abstract][Full Text] [Related]
37. [Blood coagulation system in oncological patients treated with rubomycin, adriamycin and carminomycin]. Zhukovskaia ES; Gorbunova VA; Khvatova NV Antibiotiki; 1976 Mar; 21(3):273-7. PubMed ID: 1275477 [TBL] [Abstract][Full Text] [Related]
38. [Experimental characteristics of the antileishmaniasis action of amphotericin B]. Liubimov LK; Fateeva LI; Sergeeva LA Antibiotiki; 1979 Apr; 24(4):281-4. PubMed ID: 375822 [TBL] [Abstract][Full Text] [Related]
39. [Potentiation of the selective antitumoral effect of cyclophosphamide and 5-fluorouracil by its combination with amphotericin B and diacarb]. Iaremenko KV; Bychkov IA; Pashinskiĭ VG Vopr Onkol; 1986; 32(7):61-7. PubMed ID: 3739299 [TBL] [Abstract][Full Text] [Related]
40. [Liver mono-oxygenases and the pharmacodynamics of carminomycin and rubomycin]. Bogush TA; Sitdikova SM Antibiotiki; 1984 Jun; 29(6):446-50. PubMed ID: 6476808 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]